Overview: Research & Experimental Expenditures — Section 174 in 2026
For businesses engaged in innovation, the tax treatment of Research & Experimental (R&E) expenditures under Section 174 of the Internal Revenue Code is a critical consideration. The landscape for these deductions has undergone significant changes in recent years, particularly with the enactment of the One Big Beautiful Bill Act (OBBBA). For the 2026 tax year, these changes bring a welcome return to immediate expensing for domestic R&E costs, offering substantial benefits to qualifying taxpayers.
What is the Research & Experimental Expenditures Deduction (Section 174)?
Section 174 of the Internal Revenue Code allows businesses to deduct certain costs associated with research and experimentation. Historically, these expenditures could either be expensed in the year incurred or capitalized and amortized over a period of not less than 60 months. However, for tax years beginning after December 31, 2021, the Tax Cuts and Jobs Act (TCJA) of 2017 mandated the capitalization and amortization of R&E expenses over five years for domestic research and fifteen years for foreign research. This change was widely criticized for stifling innovation and creating cash flow challenges for businesses.
The One Big Beautiful Bill Act (OBBBA), signed into law on July 4th, effectively reversed the TCJA\'s mandate for domestic R&E expenditures. Under a new addendum, Section 174A, for tax years beginning after December 31, 2024, taxpayers can once again fully deduct domestic R&E expenditures in the year they are paid or incurred [1]. This means that for the 2026 tax year, businesses can generally expense their domestic R&E costs immediately, providing a significant tax advantage.
It is crucial to distinguish Section 174 from the Research & Development (R&D) tax credit under Section 41. While both relate to research activities, Section 174 deals with the expensing or amortization of R&E costs, encompassing a broader range of expenses including direct and indirect labor, supplies, and some overheads. Section 41, on the other hand, provides a dollar-for-dollar tax credit for qualified research activities (QREs), which are a more narrowly defined subset of R&E expenses [2].
Who Qualifies for the Section 174 Deduction?
Generally, any taxpayer engaged in a trade or business that incurs research or experimental expenditures can qualify for the Section 174 deduction. The key is that the expenditures must be paid or incurred in connection with the taxpayer\'s trade or business. This includes a wide array of industries and activities aimed at developing or improving a product, process, formula, invention, or technique.
Specific Eligibility Criteria:
- Nature of Activity: The expenditures must be for research and development in the experimental or laboratory sense. This includes activities intended to discover information that eliminates uncertainty concerning the development or improvement of a product or component.
- Domestic vs. Foreign Research: For tax years beginning after December 31, 2024, only domestic R&E expenditures are eligible for immediate expensing under Section 174A. Research conducted outside the United States must still be capitalized and amortized over 15 years [1].
- Software Development: Amounts paid or incurred in connection with software development are treated as R&E expenditures eligible for immediate expensing under Section 174A [1].
- Small Businesses: The OBBBA includes particularly generous provisions for small businesses. Those defined by a gross receipts threshold established in Section 448(c) can amend tax returns as far back as 2022 to reverse the capitalization of R&E expenses. For tax years beginning in 2025, this threshold is $31 million in average annual gross receipts over the prior three tax years [1].
How to Claim the Section 174 Deduction (Forms and Process)
For the 2026 tax year, claiming the Section 174 deduction for domestic R&E expenditures will generally involve treating these costs as current business expenses. While specific forms and detailed instructions for the 2026 tax year are still being finalized by the IRS, based on the changes introduced by the OBBBA and the 2025 instructions for Form 4562, the process will likely involve:
- Form 4562, Depreciation and Amortization: This form is used to report depreciation and amortization, including Section 174 expenses. For tax years beginning in 2025, new Section 174A reinstates the deduction of domestic research or experimental expenditures as a current year business expense [3].
- Electing Expensing or Amortization: While immediate expensing is now generally available for domestic R&E, taxpayers may still have the option to elect to capitalize and amortize these expenditures over 60 months or more, or over a 10-year period [3]. This election would be made on Form 4562.
- Foreign R&E: Expenditures attributable to foreign research must still be capitalized and amortized over a 15-year period [3].
- Amended Returns for Prior Years (Small Businesses): Small businesses that capitalized R&E expenses for tax years 2022 through 2024 may be able to amend their returns to take advantage of the retroactive relief provided by the OBBBA [1].
- Interaction with Section 41 R&D Credit: Taxpayers claiming both Section 174 deductions and the Section 41 R&D credit must carefully consider the interaction between the two. The law now requires taxpayers to either reduce the deduction of R&E costs by the amount of credit received or elect to receive a reduced credit [2].
It is highly recommended to consult with a qualified tax professional to ensure proper classification and reporting of R&E expenditures, especially given the recent legislative changes.
2026 Limits, Amounts, or Rates
For the 2026 tax year, the primary limit to be aware of is the ability to **immediately deduct 100% of domestic Research & Experimental (R&E) expenditures** in the year they are paid or incurred, as per the new Section 174A of the Internal Revenue Code [1]. This is a significant change from the prior requirement to capitalize and amortize these costs over five years.
Key points for 2026:
- Domestic R&E: 100% immediate deduction [1].
- Foreign R&E: Must be capitalized and amortized over 15 years [1].
- Software Development: Costs are treated as R&E expenditures and are eligible for immediate expensing [1].
- Small Business Gross Receipts Threshold: For tax years beginning in 2025, the threshold for small businesses to amend prior returns (2022-2024) is $31 million in average annual gross receipts over the prior three tax years. This threshold is adjusted annually for inflation [1]. While the exact 2026 threshold is not yet released, it is expected to be similar or slightly higher due to inflation.
- Prior Year Capitalized Costs (2022-2024): Taxpayers can elect to accelerate the remaining deductions for these expenditures over a one-year or two-year period [1].
Common Mistakes That Cost Taxpayers Money
Navigating Section 174 can be complex, and several common mistakes can lead to missed deductions, penalties, or audit risks:
- **Confusing Section 174 with Section 41 (R&D Tax Credit):** While related, these are distinct. Section 174 governs the expensing or amortization of R&E costs, while Section 41 provides a credit for qualified research activities. Misclassifying expenses or failing to properly account for the interaction between the two can lead to errors [2].
- **Improperly Classifying Domestic vs. Foreign R&E:** With the bifurcated system, incorrectly categorizing research as domestic when it is foreign (or vice-versa) can lead to incorrect amortization periods and disallowed deductions [1].
- **Inadequate Documentation:** The IRS requires robust documentation to substantiate R&E expenditures. Failing to maintain detailed records of activities, costs, and the experimental nature of the research can result in disallowance upon audit [2].
- **Inconsistent Application of Accounting Methods:** Once a method for identifying and treating R&E is adopted, the IRS expects consistent application. Erratic classification can make it difficult for finance teams to reconcile accounts and defend claims [2].
- **Overlooking Amended Return Opportunities for Small Businesses:** Small businesses that capitalized R&E costs between 2022 and 2024 may be eligible for retroactive relief. Failing to amend prior returns to take advantage of immediate expensing can mean leaving money on the table [1].
- **Ignoring Section 280C Interactions:** When claiming both Section 174 deductions and the Section 41 R&D credit, taxpayers must consider the interaction under Section 280C. This may require reducing the R&E deduction or electing a reduced credit. Failing to plan for this interaction can lead to double-counting or disallowance [1].
IRS Code Section Reference
The primary IRS code sections governing Research & Experimental Expenditures are:
- **Internal Revenue Code (IRC) Section 174:** This section outlines the general rules for the treatment of research and experimental expenditures.
- **Internal Revenue Code (IRC) Section 174A:** Added by the One Big Beautiful Bill Act, this new section specifically allows for the immediate deduction of domestic research or experimental expenditures for tax years beginning after December 31, 2024 [1].
- **Internal Revenue Code (IRC) Section 41:** This section pertains to the Credit for Increasing Research Activities (the R&D Tax Credit), which is related but distinct from Section 174 [2].
- **Internal Revenue Code (IRC) Section 280C:** This section addresses certain credits, including the R&D credit, and their interaction with deductions, particularly Section 174 [1].
- **Internal Revenue Code (IRC) Section 448(c):** This section defines the gross receipts threshold for small businesses, relevant for the retroactive application of Section 174A [1].
Conclusion and Call to Action
The changes to Section 174 for the 2026 tax year present significant opportunities for businesses engaged in domestic research and experimental activities. The return to immediate expensing for these costs can substantially improve cash flow and reduce tax liabilities, fostering innovation and growth. However, the complexities surrounding the distinction between domestic and foreign research, the interaction with the R&D tax credit, and the need for meticulous documentation underscore the importance of expert guidance.
To ensure your business fully capitalizes on these favorable tax provisions and avoids common pitfalls, strategic planning is essential. Don\'t navigate these intricate tax laws alone. Book a consultation with the experienced tax strategists at Uncle Kam today to optimize your R&E deductions and strengthen your financial position. Visit https://unclekam.com/consultation/ to schedule your call.